APA (7th ed.) Citation

Alhalabi, O., Göttmann, M., Gold, M. P., Schlue, S., Hielscher, T., Iskar, M., . . . Goidts, V. (2024). Integration of transcriptomics, proteomics and loss-of-function screening reveals WEE1 as a target for combination with dasatinib against proneural glioblastoma. Cancer letters, 605, . https://doi.org/10.1016/j.canlet.2024.217265

Chicago Style (17th ed.) Citation

Alhalabi, Obada, et al. "Integration of Transcriptomics, Proteomics and Loss-of-function Screening Reveals WEE1 as a Target for Combination with Dasatinib Against Proneural Glioblastoma." Cancer Letters 605 (2024). https://doi.org/10.1016/j.canlet.2024.217265.

MLA (9th ed.) Citation

Alhalabi, Obada, et al. "Integration of Transcriptomics, Proteomics and Loss-of-function Screening Reveals WEE1 as a Target for Combination with Dasatinib Against Proneural Glioblastoma." Cancer Letters, vol. 605, 2024, https://doi.org/10.1016/j.canlet.2024.217265.